Enterprise Financial Services Corp reports 1.16% increase in ownership of BRM / Bristol-Myers Squibb Company

Bristol-Myers Squibb Company

DE ˙ XTRA ˙ US1101221083

47,43 € ↓ -0,01 (-0,01%)

2026-06-04
DEL PRIS

Security	DE:BRM / Bristol-Myers Squibb Company
Institution	Enterprise Financial Services Corp
Latest Disclosed Ownership	7,001 shares
Latest Disclosed Value	$ 424,610

On May 5, 2026 - Enterprise Financial Services Corp filed a 13F-HR form disclosing ownership of 7,001 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $366,992 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 14, 2026 disclosing 6,921 shares of Bristol-Myers Squibb Company. This represents a change in shares of 1.16% during the quarter. The current value of the position is $332,057 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-05-05	2026-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	7,001	80	1.16	425	13.67	0.1194
2026-01-14	2025-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	6,921	-597	-7.94	373	10.03	0.1895
2025-10-15	2025-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	7,518	204	2.79	339	0.30	0.1748
2025-08-12	2025-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	7,314	-872	-10.65	339	-32.26	0.1807
2025-05-14	2025-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	8,186	-210	-2.50	499	5.27	0.2952
2025-02-07	2024-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	8,396	-80	-0.94	475	8.22	0.2642
2024-11-12	2024-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	8,476	-775	-8.38	439	14.06	0.2556
2024-08-13	2024-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	9,251	-503	-5.16	384	-27.27	0.2365
2024-05-14	2024-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	9,754	-1,055	-9.76	529	-4.69	0.3184
2024-02-09	2023-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	10,809	-2,390	-18.11	555	-27.68	0.3379
2023-10-31	2023-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	13,199	-804	-5.74	766	-14.41	0.5293
2023-08-14	2023-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	14,003	258	1.88	895	-5.99	0.5696
2023-05-15	2023-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	13,745	-280	-2.00	953	-5.65	0.6223
2023-02-14	2022-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	14,025	70	0.50	1,009	1.71	0.6968
2022-11-14	2022-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	13,955	-353	-2.47	992	-9.90	0.7394
2022-08-09	2022-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	14,308	340	2.43	1,101	7.94	0.2145
2022-05-16	2022-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	13,968	257	1.87	1,020	19.30	0.1674
2022-02-14	2021-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	13,711	-18,763	-57.78	855	-55.49	0.1312
2021-11-15	2021-09-30	13F	Bristol-Myers S	Common Stock	110122108	32,474	17,222	112.92	1,921	88.52	0.2486
2021-08-16	2021-06-30	13F	Bristol-Myers S	Common Stock	110122108	15,252	-444	-2.83	1,019	2.93	0.1629
2021-05-13	2021-03-31	13F	Bristol-Myers S	Common Stock	110122108	15,696	-196	-1.23	990	0.41	0.1766
2021-02-12	2020-12-31	13F	Bristol-Myers S	Common Stock	110122108	15,892	-1,106	-6.51	986	-3.80	0.1873
2020-11-13	2020-09-30	13F	Bristol-Myers S	Common Stock	110122108	16,998	-666	-3.77	1,025	-1.35	0.2119
2020-08-04	2020-06-30	13F	Bristol-Myers S	Common Stock	110122108	17,664	-6,170	-25.89	1,039	-21.82	0.2241
2020-05-15	2020-03-31	13F	Bristol-Myers S	Common Stock	110122108	23,834	728	3.15	1,329	-10.38	0.3353
2020-01-28	2019-12-31	13F	Bristol-Myers S	Common Stock	110122108	23,106	-453	-1.92	1,483	24.20	0.3231
2019-10-31	2019-09-30	13F	Bristol-Myers S	Common Stock	110122108	23,559	-2,833	-10.73	1,194	-0.25	0.2718
2019-07-30	2019-06-30	13F	Bristol-Myers S	Common Stock	110122108	26,392	-3,699	-12.29	1,197	-16.59	0.2600
2019-04-26	2019-03-31	13F	BRISTOL-MYERS S	COMMON STOCK	110122108	30,091	13,899	85.84	1,435	70.43	0.3132
2019-01-25	2018-12-31	13F	BRISTOL MYERS SQUIBB	COMMON STOCK	110122108	16,192	-418	-2.52	842	-18.41	0.5311
2018-10-26	2018-09-30	13F	BRISTOL MYERS SQUIBB	COMMON STOCK	110122108	16,610	-265	-1.57	1,032	10.49	0.5410
2018-07-27	2018-06-30	13F	BRISTOL MYERS SQUIBB	COMMON STOCK	110122108	16,875	-400	-2.32	934	-14.47	0.4737
2018-04-27	2018-03-31	13F	BRISTOL MYERS SQUIBB	COMMON STOCK	110122108	17,275	5,650	48.60	1,092	53.16	0.5623
2018-01-26	2017-12-31	13F	BRISTOL MYERS SQUIBB	COMMON STOCK	110122108	11,625	993	9.34	713	5.16	0.3466
2017-10-27	2017-09-30	13F	BRISTOL MYERS SQUIBB	COMMON STOCK	110122108	10,632	-11,662	-52.31	678	-45.41	0.3355
2017-07-28	2017-06-30	13F	BRISTOL MYERS SQUIBB	COMMON STOCK	110122108	22,294	-149	-0.66	1,242	1.80	0.6198
2017-04-27	2017-03-31	13F	BRISTOL MYERS SQUIBB	COMMON STOCK	110122108	22,443	-255	-1.12	1,220	-8.06	0.6013
2017-01-26	2016-12-31	13F	BRISTOL MYERS SQUIBB	COMMON STOCK	110122108	22,698	12,001	112.19	1,327	129.98	0.6674
2016-10-28	2016-09-30	13F	BRISTOL MYERS SQUIBB	COMMON STOCK	110122108	10,697	-509	-4.54	577	-29.98	0.3267
2016-07-29	2016-06-30	13F	BRISTOL MYERS SQUIBB	COMMON STOCK	110122108	11,206	3,206	40.08	824	61.25	0.4854
2016-04-29	2016-03-31	13F	BRISTOL MYERS SQUIBB	COMMON STOCK	110122108	8,000	-78	-0.97	511	-8.09	0.3082
2016-01-29	2015-12-31	13F	BRISTOL MYERS SQUIBB	COMMON STOCK	110122108	8,078	586	7.82	556	25.23	0.3298
2015-10-29	2015-09-30	13F	BRISTOL MYERS SQUIBB	COMMON STOCK	110122108	7,492	-103	-1.36	444	-12.08	0.2840
2015-07-27	2015-06-30	13F	BRISTOL MYERS SQUIBB	COMMON STOCK	110122108	7,595	-228	-2.91	505	0.00	0.2985
2015-04-29	2015-03-31	13F	BRISTOL MYERS SQUIBB	COMMON STOCK	110122108	7,823	2,907	59.13	505	73.54	0.2966
2015-01-23	2014-12-31	13F	BRISTOL MYERS SQUIBB	COMMON STOCK	110122108	4,916	170	3.58	291	19.75	0.1762
2014-10-24	2014-09-30	13F	BRISTOL MYERS SQUIBB	COMMON STOCK	110122108	4,746	-3,874	-44.94	243	-41.87	0.1539
2014-07-24	2014-06-30	13F	BRISTOL MYERS SQUIBB	COMMON STOCK	110122108	8,620	-731	-7.82	418	-13.99	0.2493
2014-04-24	2014-03-31	13F	BRISTOL MYERS SQUIBB	COMMON STOCK	110122108	9,351	44	0.47	486	-1.62	0.2984
2014-01-30	2013-12-31	13F	BRISTOL MYERS SQUIBB	COMMON STOCK	110122108	9,307	102	1.11	494	15.96	0.2864
2013-10-25	2013-09-30	13F	BRISTOL MYERS SQUIBB	COMMON STOCK	110122108	9,205	11	0.12	426	3.65	0.2691
2013-07-25	2013-06-30	13F	BRISTOL MYERS SQUIBB	COMMON STOCK	110122108	9,194	9,194		411		0.2819

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.